Back

Direct effects of ponatinib on vascular endothelial cells: a potential explanation for development of vascular adverse events in CML patients

22 April 2018 (14:15 - 14:30)
Organised by: Logo
Congress Presentation Part of: Late Breaking Trial session Drugs, Drug Targets Open Access Frontiers in CardioVascular Biology 2018 Council on Basic Cardiovascular Science

About the speaker

Photo
Doctor Emir Hadzijusufovic

Ludwig Boltzmann Cluster Oncology, Vienna (Austria)

5 More presentations in this session

Presentation thumbnail
IkB kinase 2 in atherosclerosis
Doctor M. Mussbacher (Vienna, AT)
Presentation thumbnail
Targeted theranostic microbubbles for the delivery of MicroRNA-126: diagnosis and localised treatment/prevention of abdominal aortic aneurysm
Professor K. Peter (Melbourne, AU)
Slides
Presentation thumbnail
Electrically silent and stimulable iPSC-derived cardiomyocytes using RNA-guided epigenome editing
Professor J. Hulot (Paris, FR)
Presentation thumbnail
A three-step approach to identify shear stress-sensitive endothelial microRNAs for the optimization of vasculoprotective exercise regimes
Professor B. Schmitz (Ennepetal, DE)
Presentation thumbnail
Potentiated beta-adrenergic effect on calcium handling in autophagy-defective mouse cardiomyocytes
Associate Professor S. Sedej (Graz, AT)

Access the full session

Session thumbnail
Late Breaking Trial session

The Event

Event poster

Frontiers in CardioVascular Biology 2018

22 April 2018 14:15 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources